Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

		Phase:		Phase 3

		Treatment ID#:		1924

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed IF you are interested in this trial, contact them as soon as possible, as there is a strict window of opportunity to join. Some of our members missed by a few days.

		Last Updated:		07/18/2010

		Tumor Types:		Glioblastoma Multiforme


		Comments:		See http://virtualtrials.com/news3.cfm?item=4336 for results of a small pilot study of this treatment and here for a lecture about the device from our recent brain tumor conference!

		Treatment Type:		Chemotherapy Less-Toxics

		Contact:		Karen Fink MD, PHD Baylor University Medical Center at Dallas Neuro-Oncology Associates 3600 Gaston Ave. Barnett Tower Suite 605 Dallas, TX 75246 USA Phone: 214-820-8690 Fax: 214-820-8691 E-mail: Website: www.neuro-oncologyassociates.com

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By